| 查看: 908 | 回复: 5 | |||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
wqssfj1铁杆木虫 (著名写手)
|
[求助]
求助翻译
|
||
|
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 分析句子成份加翻译，谢谢！ |
回复此楼» 收录本帖的淘帖专辑推荐
 精品翻译集锦 |
» 猜你喜欢
0805 316求调剂
已经有6人回复
-
085601求调剂总分293英一数二
已经有3人回复
-
考研调剂
已经有3人回复
-
08工学调剂
已经有17人回复
-
340求调剂
已经有4人回复
-
311求调剂
已经有3人回复
-
食品专硕 一志愿双一流 328
已经有4人回复
-
材料调剂
已经有6人回复
-
300分，材料，求调剂，英一数二
已经有5人回复
-
求调剂，一志愿:南京航空航天大学大学 ，080500材料科学与工程学硕，总分289分
已经有5人回复
wqssfj1
铁杆木虫 (著名写手)
- 翻译EPI: 1
- 应助: 2 (幼儿园)
- 金币: 5947.4
- 散金: 21
- 红花: 3
- 帖子: 1448
- 在线: 252.5小时
- 虫号: 1391164
- 注册: 2011-09-05
- 专业: 药物资源
3楼2012-06-25 13:15:47
qin20010
木虫 (小有名气)
小木虫博士生导师
- 应助: 0 (幼儿园)
- 金币: 2012.8
- 帖子: 275
- 在线: 27.4小时
- 虫号: 346589
- 注册: 2007-04-15
- 性别: GG
- 专业: 催化化学
2楼2012-06-25 10:59:20
17953216334
银虫 (小有名气)
- 翻译EPI: 1
- 应助: 5 (幼儿园)
- 金币: 1241.8
- 红花: 3
- 帖子: 130
- 在线: 116.5小时
- 虫号: 1787064
- 注册: 2012-04-30
- 专业: 高分子助剂
4楼2012-06-25 13:24:01
readbycandle
木虫 (著名写手)
A thinking worm
- 翻译EPI: 55
- 应助: 22 (小学生)
- 贵宾: 0.2
- 金币: 7100.6
- 红花: 13
- 帖子: 2158
- 在线: 460.5小时
- 虫号: 1793835
- 注册: 2012-05-03
- 专业: 美国文学
【答案】应助回帖
|
However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 这是两个并列的句子。an evaluationketed....was performed and “Localized exfoliation or blisters” were added . 翻译： However, an evaluation of all reports related to skin events received by Novartis from marketed use of vildagliptin (includes Galvus and Eucreas) since the original placing on the market to 29 Feb 2012 was performed 不过，已对自投放市场以来至2012年2月29日诺华公司收到的关于使用vildagliptin (包括Galvus and Eucreas)引起的皮肤反应的所有报告进行了评估， and as post-marketing experience “Localized exfoliation or blisters” (frequency not known) were added as the adverse drug reactions in the current CDS. 并将“可以引起局部脱皮或水泡”作为市场反馈信息加入目前CDS的副作用说明中。 |
5楼2012-06-28 17:36:35
